Abnova (Taiwan) Corporation (TPE:4133)
21.75
+0.15 (0.69%)
Apr 29, 2026, 1:30 PM CST
Abnova (Taiwan) Market Cap
Abnova (Taiwan) has a market cap or net worth of 1.32 billion as of April 29, 2026. Its market cap has decreased by -23.82% in one year.
Market Cap
1.32B
Enterprise Value
957.71M
Revenue
351.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.75
Market Cap Chart
Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.32B, a decrease of -54.73%. That is a compound annual growth rate of -4.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 1.34B |
| Enimmune | 1.36B |
| NeoCore Technology | 1.41B |
| BiOptic | 1.21B |
| LabTurbo Biotech | 1.15B |
| GeneReach Biotechnology | 1.13B |
| Holy Stone Healthcare | 1.12B |
| GenMont Biotech Incorporation | 1.54B |